Argent BioPharma licences non-core cannabis genetics in global deal | Stockhead

Argent BioPharma signs an exclusive worldwide licensing deal with Thai Phytomed International for the commercial development of four proprietary canna…

Continue in Briflio to read, react, comment, and share.